‘It Takes A World’ To Achieve Life-Saving Cures. Let’s Not Penalize It
The post ‘It Takes A World’ To Achieve Life-Saving Cures. Let’s Not Penalize It appeared on BitcoinEthereumNews.com. View of the Earth as seen from the Command Module during NASA’s Apollo 12 mission, between November … More 14 and 24, 1969. (Photo by NASA/Interim Archives/Getty Images) Getty Images The path to rapid attainment of pharmaceutical advances is a global endeavor. That’s because the more hands, machines, and minds at work in the creation of that which will vanquish cancer in all its forms, heart disease, and surely future diseases we haven’t lived long enough to get, the quicker we will arrive at those advances. What’s sad is that the above even needs to be said. Going back to the pin factory that Adam Smith visited in the 18th century, to the car factories that Henry Ford designed in the 20th century, to the iPhones (aka supercomputers) that are a consequence of innovative production on six different continents, it’s long been known that rapid progress is an effect of spreading production across as many as possible. Applied to life-saving drugs, it will take the “closed economy” that is the world economy to turn global killers of today into yesterday’s afterthoughts. Stop and think about this now, and with foreign income of U.S. pharmaceutical companies well in mind. They don’t have overseas operations just because, or even to escape U.S. taxation, but instead because innovation doesn’t stop at U.S. borders. Much as the iPhone wouldn’t be the iPhone without foreign cooperation, present and future pharmaceutical advances won’t come to be without the collaboration of minds, hands and machines the world over. In other words, a tax on foreign pharmaceutical production is a tax on domestic pharmaceutical production in two ways. To which some might say so what, American pharma is the best of the lot. No argument there. Just the same, the best American pharmaceutical firms have acquired businesses around…
The post ‘It Takes A World’ To Achieve Life-Saving Cures. Let’s Not Penalize It appeared on BitcoinEthereumNews.com.
View of the Earth as seen from the Command Module during NASA’s Apollo 12 mission, between November … More 14 and 24, 1969. (Photo by NASA/Interim Archives/Getty Images) Getty Images The path to rapid attainment of pharmaceutical advances is a global endeavor. That’s because the more hands, machines, and minds at work in the creation of that which will vanquish cancer in all its forms, heart disease, and surely future diseases we haven’t lived long enough to get, the quicker we will arrive at those advances. What’s sad is that the above even needs to be said. Going back to the pin factory that Adam Smith visited in the 18th century, to the car factories that Henry Ford designed in the 20th century, to the iPhones (aka supercomputers) that are a consequence of innovative production on six different continents, it’s long been known that rapid progress is an effect of spreading production across as many as possible. Applied to life-saving drugs, it will take the “closed economy” that is the world economy to turn global killers of today into yesterday’s afterthoughts. Stop and think about this now, and with foreign income of U.S. pharmaceutical companies well in mind. They don’t have overseas operations just because, or even to escape U.S. taxation, but instead because innovation doesn’t stop at U.S. borders. Much as the iPhone wouldn’t be the iPhone without foreign cooperation, present and future pharmaceutical advances won’t come to be without the collaboration of minds, hands and machines the world over. In other words, a tax on foreign pharmaceutical production is a tax on domestic pharmaceutical production in two ways. To which some might say so what, American pharma is the best of the lot. No argument there. Just the same, the best American pharmaceutical firms have acquired businesses around…
What's Your Reaction?
